Lawrence Fong
University of California, San Francisco
H-index: 68
North America-United States
Top articles of Lawrence Fong
PVRL2 Suppresses Antitumor Immunity through PVRIG-and TIGIT-independent Pathways
Cancer Immunology Research
2024/5/2
Puck member for fidget accessory
2024/4/16
Abstract LB237: PVRL2 suppresses antitumor immune responses through PVRIG-and TIGIT-independent pathways
Cancer Research
2024/4/5
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy
Blood Advances
2024/4/4
Kai Wu
H-Index: 17
Elizabeth Mccarthy
H-Index: 1
Erik Hansen
H-Index: 1
Chun Jimmie Ye
H-Index: 28
Lawrence Fong
H-Index: 45
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer
Clinical Genitourinary Cancer
2024/4/1
Randomized phase II study evaluating the addition of pembrolizumab to radium-223 in metastatic castration-resistant prostate cancer
2021/2/20
Lucia Kwak
H-Index: 12
Abhishek Tripathi
H-Index: 17
Christopher Sweeney
H-Index: 3
Lawrence Fong
H-Index: 45
Responders to combination radiation and PD-1 blockade demonstrate reduced myeloid immunosuppression and enhanced interferon signaling in oligometastatic prostate cancer patients
Cancer Research
2024/3/22
Expansion and persistence of anti-BCMA CAR T cells correlates with durability of responses in multiple myeloma patients
Cancer Research
2024/3/22
NTX-470, a novel multispecific T cell engager expressed from mRNA targets PSMA and STEAP1 prostate cancer antigens to generate enhanced functional activity
Cancer Research
2024/3/22
Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with prostate cancer progression
Cancer Research
2024/3/22
Eliezer Van Allen
H-Index: 66
Lawrence Fong
H-Index: 45
Flexible mount for phone grip
2024/3/19
Mount accessory for phone grip
2024/2/27
Outcomes of high-grade immune checkpoint inhibitor hepatitis in hospitalized and non-hospitalized patients
Clinical Gastroenterology and Hepatology
2024/2/23
Immune modulation with RANKL blockade through denosumab treatment in patients with cancer
Cancer Immunology Research
2024/2/19
Hai Yang
H-Index: 4
Li Zhang
H-Index: 7
Meenal Sinha
H-Index: 7
Mark Anderson
H-Index: 5
Lawrence Fong
H-Index: 45
Disease-associated antigens and methods of use thereof
2024/2/6
Association of HER2 expression in advanced urothelial carcinoma (aUC) and treatment outcomes with immune checkpoint inhibitors and enfortumab vedotin.
2024/2/1
Efficacy outcomes and biomarker analysis from phase II trial of escalating doses of neoadjuvant atezolizumab in patients with muscle-invasive urothelial carcinoma ineligible …
2024/2/1
Li Zhang
H-Index: 7
Vipul Kumar
H-Index: 3
Xiaolin Zhu
H-Index: 14
Jonathan Chou
H-Index: 18
Lawrence Fong
H-Index: 45
A phase 1/2 study of ONCT-534, a dual-action androgen receptor inhibitor (DAARI), in patients with metastatic castration-resistant prostate cancer.
2024/2/1
Peter Nelson
H-Index: 25
Lawrence Fong
H-Index: 45
Implementing consultation audio recording applications to improve informed decision-making (IDM) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC …
2024/2/1
Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer
Cancer Research Communications
2024/1/25
Hai Yang
H-Index: 4
Brandon Chen
H-Index: 0
Phi Le
H-Index: 3
Tony Li
H-Index: 6
Li Zhang
H-Index: 7
Lawrence Fong
H-Index: 45
